Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
HIV Clinical Pharmacist Services
The HIV Clinical Pharmacist Services intervention shortens the time between referral to and engagement in care by allowing newly referred clients to see pharmacists in addition to other clinical providers for their initial appointment. This intervention is supported by findings from a retrospective cohort study that took place from 2013 to 2017 at a RWHAP-funded clinic. In addition to significantly decreasing the time between referral and initial visit, clients who saw a pharmacist also experienced shortened time to antiretroviral therapy initiation and viral suppression compared to those who only saw non-pharmacist providers.Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
-
Medicare Enrollment and Coverage for Ryan White HIV/AIDS Program (RWHAP) Clients
Best practices for providing Medicare enrollment support.Resource updated 03/11/2024
-
RWHAP Part A Guidance for Planning Bodies on Supporting People with Lived Experience
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
News Article updated on 12/19/2022 -
Clinical Quality Management: Best Practices, Implementation, and Development
Quality improvement presentations on process development and utilizing data to inform CQM.Resource (Conference Presentation) updated 09/14/2023
-
Division of Community HIV/AIDS Programs: RWC 2022 Business Day Meeting
HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.
Resource (Conference Presentation) updated 09/14/2023
-
Simplifying Salvage Antiretroviral Regimens in Treatment-Experienced PLWH
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
-
HIV Clinic Staff and Community Perspectives on Long-Acting Injectable ART in New York City
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
-
Applying technological innovation: Harnessing an electronic patient portal to achieve a patient-centered approach to recertification
Using a multidisciplinary approach to harness the electronic patient portal for completion of RWHAP six-month recertification documents, we were able to create a more patient-centered method that complies with program requirements. We will discuss the challenges, opportunities, and results of using such technology in program recertification.
Resource (Conference Presentation) updated 09/14/2023
-
I am Somebody! Developing Leaders in your PC/PB
Discussion of ways to develop leaders in your Planning Council/Planning Body (PC/PB).Resource updated 01/05/2024
-
Promising Practices: The Impact of COVID-19 Related Policy Changes On Enrollment Capacity Within California's ADAP
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
-
Assessing Medication Access Barriers in Patients Living with HIV
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
-
Listening Session on Policy Clarification Notice 16-02 Ryan White HIV/AIDS Program Services: Eligible Individuals and Allowable Uses of Funds
Listening Session on how Policy Clarification Notice 16-02 and how the HRSA HAB RWHAP service categories and allowable uses of funds can be refreshed to best reflect new and emerging needs, science, and service delivery models.
Resource (Conference Presentation) updated 09/14/2023
-
Community Co-Creation: Engaging Traditional and Nontraditional Partners in a National Viral Suppression Campaign
HHS process for development of the “I Am a Work of ART” viral suppression campaign, in collaboration with community partners. of the National HIV/AIDS Strategy.
Resource (Conference Presentation) updated 09/14/2023
-
RWHAP Part C Allocations Report Manual
Instructions on how all Ryan White HIV/AIDS Program (RWHAP) Part C recipients can access, complete, and submit the RWHAP Part C Allocations Report.
Resource updated 06/27/2024
-
Joy in Workplace
Review of leadership and workplace changes on creating an improved work environment.Resource updated 11/01/2023
-
RWHAP Part C, Part D, & Part F Dental Programs Stakeholder Meeting - April 2023
HAB updates, infant feeding for individuals with HIV in the US, and Building Collaborative Partnerships.Resource updated 01/09/2024
-
Long-Acting Injectables for HIV Antiretroviral Therapy
Guide for EHE jurisdictions on what they can do to enhance implementation of long-acting injectable antiretroviral therapy.Resource updated 04/12/2024
-
STI Implementation Plan Released
HHS has released an implementation plan on specific actions for entities to take in preventing and treating sexually transmitted infections (STI).News Article updated on 06/13/2023 -
Key Stakeholder Engagement Matters! Syndemics, Health Disparities, and Coordinating Systems of Care
Discussion of key stakeholder engagement in your Planning Council/Planning Body (PC/PB).Resource updated 05/09/2024